Clinical Trial Update: Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated the efficacy of switching to DuoTrav (travoprost/timolol) from prior glaucoma therapy and was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• DuoTrav (travoprost; timolol (fixed-dose combination))

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma | Phase 4 | Status: TERMINATED